Cited by 258Digital Radiography and Breast ImagingCancer Risks and FactorsEstrogen and related hormone effects

Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women

Tamimi, R. M., Byrne, C., Colditz, G. A., Hankinson, S. E.·2007·JNCI Journal of the National Cancer Institute

Abstract

BACKGROUND: Mammographic density and circulating sex hormones are two well-confirmed predictors of breast cancer risk. Whether mammographic density reflects levels of endogenous sex hormones is unclear. We examined whether these predictors are independently associated with breast cancer risk in a prospective study. METHODS: We conducted a nested case-control study within the Nurses' Health Study cohort of 253 case subjects with breast cancer and 520 control subjects. All participants were postmenopausal women who were not using postmenopausal hormones at the time of both blood collection and mammography. Plasma levels of estradiol, free estradiol, testosterone, and free testosterone were evaluated. Mammographic density was assessed by use of computer-assisted analysis of mammograms. Logistic regression models that were adjusted for matching variables and potential confounders were used to calculate relative risks (RRs) and 95% confidence intervals (CIs). All statistical tests were two-sided. RESULTS: Levels of circulating sex steroids and mammographic density were both statistically significantly and independently associated with breast cancer risk. The relative risk of breast cancer associated with mammographic density (RR for highest quartile compared with lowest quartile = 3.8, 95% CI = 2.2 to 6.6; P(trend)<.001) changed little when the analysis was adjusted for circulating estradiol (RR = 3.9, 95% CI = 2.2 to 6.9; P(trend)<.001) or circulating testosterone (RR = 4.1, 95% CI = 2.3 to 7.2; P(trend)<.001). Circulating levels of estradiol (RR = 2.4, 95% CI = 1.4 to 4.0) and of testosterone (RR = 2.0, 95% CI = 1.2 to 3.1) were both associated with breast cancer risk, before and after adjustment for mammographic density. In a joint analysis of mammographic density and plasma testosterone, the risk of breast cancer was highest in the highest tertiles of both relative to the lowest tertiles of both (RR = 6.0, 95% CI = 2.6 to 14.0). A similar pattern was observed in the joint analysis of estradiol and mammographic density (RR = 4.1, 95% CI = 1.7 to 9.8). CONCLUSIONS: Circulating sex steroid levels and mammographic density appear strongly and independently associated with the risk of breast cancer in postmenopausal women.

Integrity signals

Registry

Crossref · 10.1093/jnci/djm062

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Elevated serum estradiol is weakly associated with increased breast cancer risk.

    “Elevated serum levels of estradiol are weakly associated with increased breast cancer risk (62), while expression of estrogen receptor (ER)-α is a favorable prognostic factor (63).”

    From Diabetes and Cancer (2010) · cites this paper as [62]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tamimi, R. M., Byrne, C., Colditz, G. A., & Hankinson, S. E.
Affiliations
Brigham and Women's Hospital (US)
Venue
JNCI Journal of the National Cancer Institute
Published
2007-07-24
Volume
99
Issue
15
Pages
1178-1187
ISSN
  • 0027-8874 (ISSN-L)
  • 1460-2105
OpenAlex
W2161966331
Cited by
258
References
74
Citations by year
2026: 2 · 2025: 5 · 2024: 12 · 2023: 8 · 2022: 12 · 2021: 14 · 2020: 12 · 2019: 8 · 2018: 13 · 2017: 17 · 2016: 16 · 2015: 18 · 2014: 13 · 2013: 16 · 2012: 12
FWCI
16.77
Type
journal article
Language
en
Open access
closed
Locations
  • JNCI Journal of the National Cancer Institute (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
National Cancer Institute (CA 087969, CA-049449, R29CA075016, CA 089393, P01CA087969, CA075016, P50CA089393)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Digital Radiography and Breast Imaging
  • Health Sciences › Medicine › Oncology › Cancer Risks and Factors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
Keywords
breast cancer risk, breast density, endogenous sex hormones, estradiol, free estradiol, testosterone, free testosterone, postmenopausal women, breast cancer risk factors, Nurses' Health Study, progesterone receptor status, hormone-independent breast cancer
MeSH terms
Adipose Tissue, Age Factors, Aged, Aged, 80 and over, Breast, Breast Neoplasms, Estradiol, Estrogens, Female, Humans, Mammography, Middle Aged, Neoplasm Proteins, Neoplasms, Hormone-Dependent, Nurses, Progesterone, Receptors, Estrogen, Receptors, Progesterone, Risk, Testosterone, United States, Cohort Studies, Confidence Intervals, Case-Control Studies, Reproductive History, Postmenopause

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review